Company news
OncoSil Medical Ltd news in 2017
OncoSil Medical Ltd's news releases, calls and decks from 2017, newest first.
Progress Update on Global Pancreatic Cancer Clinical Study
December 20, 2017
Positive Early Study Results Presented at EANM Congress
October 22, 2017
R&D Refund
September 24, 2017
Progress update on Global Pancreatic Cancer Clinical Study
September 21, 2017
Appendix 4E - Preliminary Final Report 30 June 2017
August 24, 2017
First UK subject recruited
August 21, 2017
CE Mark & Quarterly Activity Update
July 30, 2017
Second subject recruited at Monash Health Melbourne
May 10, 2017
Appendix 4C and Quarterly update
April 26, 2017
First OncoSil Device Implantation procedure completed
April 25, 2017
Specialised Therapeutics Australia supporting OncoSil study
April 19, 2017
US IRB Approval, MD Anderson Cancer Centre
April 18, 2017
UK Central Ethics Approval
April 4, 2017
First subject recruited
March 27, 2017
Appendix 4D & Half Year Accounts
February 22, 2017
MHRA Approval to commence study in UK
February 12, 2017
Ethics Approval for OncoPac Clinical Study
February 1, 2017
Appendix 4C - Quarterly Cash Flow
January 26, 2017
Decks in 2017
- Australian Biotech Invest 2017
Conference · 15 slides · Oct 24, 2017